✦ LIBER ✦

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin compared with α-glucosidase inhibitor in Japanese patients with type 2 diabetes inadequately controlled on sulfonylurea alone (SUCCESS-2): a multicenter, randomized, open-label, non-i

✍ Scribed by Kobayashi, K.; Yokoh, H.; Sato, Y.; Takemoto, M.; Uchida, D.; Kanatsuka, A.; Kuribayashi, N.; Terano, T.; Hashimoto, N.; Sakurai, K.; Hanaoka, H.; Ishikawa, K.; Onishi, S.; Yokote, K.

Book ID: 125500429
Publisher: John Wiley and Sons
Year: 2014
Tongue: English
Weight: 534 KB
Volume: 16
Category: Article
ISSN: 1462-8902
DOI: 10.1111/dom.12264

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of the dipeptidyl pe

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, compared with the sulfonylurea, glipizide, in patients with type 2 diabetes inadequately controlled on metformin alone: a randomized, double-blind, non-inferiority trial

✍ M. A. Nauck; G. Meininger; D. Sheng; L. Terranella; P. P. Stein; Sitagliptin Stu 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 191 KB

Efficacy and safety of the dipeptidyl pe

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor gemigliptin compared with sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes inadequately controlled with metformin alone

✍ Rhee, E. J.; Lee, W. Y.; Min, K. W.; Shivane, V. K.; Sosale, A. R.; Jang, H. C.; 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 509 KB

Efficacy and Safety of the Dipeptidyl Pe

Efficacy and Safety of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin Added to Ongoing Metformin Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Alone

✍ Charbonnel, B.; Karasik, A.; Liu, J.; Wu, M.; Meininger, G. 📂 Article 📅 2006 🏛 American Diabetes Association 🌐 English ⚖ 148 KB

Efficacy and safety of the dipeptidyl pe

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin

✍ K. Hermansen; M. Kipnes; E. Luo; D. Fanurik; H. Khatami; P. Stein; Sitagliptin S 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 175 KB

The efficacy and safety of the dipeptidy

The efficacy and safety of the dipeptidyl peptidase-4 inhibitor saxagliptin in treatment-naïve patients with type 2 diabetes mellitus: a randomized controlled trial

✍ Robert Frederich, Robert McNeill, Niklas Berglind, Douglas Fleming, Roland Chen 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 239 KB

Serum level of soluble CD26/dipeptidyl p

Serum level of soluble CD26/dipeptidyl peptidase-4 (DPP-4) predicts the response to sitagliptin, a DPP-4 inhibitor, in patients with type 2 diabetes controlled inadequately by metformin and/or sulfonylurea

✍ Yoshimasa Aso; Noriyuki Ozeki; Tomoko Terasawa; Rika Naruse; Kenji Hara; Mariko 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 210 KB